share_log

BMO Capital Downgrades Sabra Health Care REIT to Market Perform, Announces $16 Price Target

BMO Capital Downgrades Sabra Health Care REIT to Market Perform, Announces $16 Price Target

BMO Capital將Sabra Health Care REIT的評級下調至市場表現,宣佈目標股價爲16美元
Benzinga ·  2023/10/17 07:19

BMO Capital analyst John Kim downgrades Sabra Health Care REIT (NASDAQ:SBRA) from Outperform to Market Perform and announces $16 price target.

蒙特利爾銀行資本分析師John Kim將Sabra Health Care REIT(納斯達克:SBRA)的評級從表現優於大盤下調至市場表現,並宣佈16美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論